Diseases and physical health conditions
Key indicators
Selected geographical area: Canada
-
1,730 per 100,000 people
Results
All (5)
All (5) ((5 results))
- Articles and reports: 82-003-X19970013055Geography: CanadaDescription:
This aritcle analyzes abdominal aortic aneurysm (AAA) surgery rates by sex for inpatients of Canadian hospitals. Possible reasons for the observed gender differences in surgery rates are discussed.
Release date: 1997-07-28 - 2. Update on breast cancer mortality, 1995 ArchivedArticles and reports: 82-003-X19970013057Geography: CanadaDescription: This article updates recently published information on Canadian breast cancer mortality, highlighting a lower rate in 1995, a marked decline in the rate since 1990, and possible factors contributing to this trend.Release date: 1997-07-28
- Articles and reports: 11F0019M1997099Geography: CanadaDescription:
Context : Lung cancer has been the leading cause of cancer deaths in Canadian males for many years, and since 1994, this has been the case for Canadian femalesas well. It is therefore important to evaluate the resources required for its diagnosis and treatment. This article presents an estimate of the direct medical costsassociated with the diagnosis and treatment of lung cancer calculated through the use of a micro-simulation model. For disease incidence, 1992 was chosen as thereference year, whereas costs are evaluated according to the rates that prevailed in 1993.Methods : A model for lung cancer has been incorporated into the Population Health Model (POHEM). The parameters of the model were drawn in part fromStatistics Canada's Canadian Cancer Registry (CCR), which provides information on the incidence and histological classification of lung cancer cases in Canada.The distribution of cancer stage at diagnosis was estimated by using information from two provincial cancer registries. A team of oncologists derived "typical" treatment approaches reflective of current practice, and the associated direct costs were calculated for these approaches. Once this information and the appropriatesurvival curves were incorporated into the POHEM model, overall costs of treatment were estimated by means of a Monte Carlo simulation.Results: It is estimated that overall, the direct medical costs of lung cancer diagnosis and treatment were just over $528 million. The cost per year of life gained as aresult of treatment of the disease was approximately $19,450. For the first time in Canada, it was possible to estimate the five year costs following diagnosis, bystage of the disease at the time of diagnosis. It was possible to estimate the cost per year of additional life gained for three alternative treatments of non small-cell lungcancer (NSCLC). Sensitivity analyses showed that these costs varied between $1,870 and $6,860 per year of additional life gained, which compares favourablywith the costs that the treatment of other diseases may involve.Conclusions: Contrary to widespread perceptions, it appears that the treatment of lung cancer is effective from an economic standpoint. In addition, the use of amicro-simulation model such as POHEM not only makes it possible to incorporate information from various sources in a coherent manner but also offers thepossibility of estimating the effect of alternative medical procedures from the standpoint of financial pressures on the health care system.
Release date: 1997-04-22 - 4. Cancer incidence and mortality, 1997 ArchivedArticles and reports: 82-003-X19960043024Geography: CanadaDescription:
In 1997, there will be an estimated 130,800 new cases of cancer and 60,700 deaths from the disease, an increase of one third and one quarter, respectively, over 1987. These increases are due mainly to the growth and aging of the population. (All figures exclude non-melanoma skin cancer.) In 1997, three types of cancer will account for at least half of all new cases in men and women: prostate, lung and colorectal cancer for men; breast, lung and colorectal cancer for women. Lung cancer will be the leading cause of cancer death in 1997, resulting in one-third of cancer deaths for men and almost one-quarter of cancer deaths for women. Among women, overall trends in age-standardized rates of cancer incidence and mortality have remained relatively stable since 1985, as large increases in the rate of lung cancer have been offset by declining or stable rates for most other forms. Among men, the overall incidence rate is rising slightly as a result of the sharp increase in the incidence of prostate cancer. The mortality rate for men peaked in 1988 and has since declined, because of decreases in the rates for lung, colorectal and some other cancers. This article presents information on trends since the mid-1980s in cancer incidence and mortality, adapted from Canadian Cancer Statistics 1987.
Release date: 1997-04-21 - 5. Canadian Cancer Statistics ArchivedTable: 82F0008XDescription:
The special ten year anniversary edition of Canadian cancer statistics 1997 represents a collaborative effort between Statistics Canada, the National Cancer Institute of Canada, Health Canada, the Canadian Cancer Society, and provincial/territorial cancer registries. This 71 page monograph contains estimates of cancer incidence and mortality for 1997, historical (actual and estimated) data from 1969 to 1997, and selected indicators on the burden of cancer. Estimates were produced by modelling actual cancer incidence and mortality data by province for selected cancer sites. The special topic this year is a comparison of the burden of cancer in Canada in 1997 to that reported in the first edition in 1987.
Release date: 1997-03-06
Data (1)
Data (1) ((1 result))
- 1. Canadian Cancer Statistics ArchivedTable: 82F0008XDescription:
The special ten year anniversary edition of Canadian cancer statistics 1997 represents a collaborative effort between Statistics Canada, the National Cancer Institute of Canada, Health Canada, the Canadian Cancer Society, and provincial/territorial cancer registries. This 71 page monograph contains estimates of cancer incidence and mortality for 1997, historical (actual and estimated) data from 1969 to 1997, and selected indicators on the burden of cancer. Estimates were produced by modelling actual cancer incidence and mortality data by province for selected cancer sites. The special topic this year is a comparison of the burden of cancer in Canada in 1997 to that reported in the first edition in 1987.
Release date: 1997-03-06
Analysis (4)
Analysis (4) ((4 results))
- Articles and reports: 82-003-X19970013055Geography: CanadaDescription:
This aritcle analyzes abdominal aortic aneurysm (AAA) surgery rates by sex for inpatients of Canadian hospitals. Possible reasons for the observed gender differences in surgery rates are discussed.
Release date: 1997-07-28 - 2. Update on breast cancer mortality, 1995 ArchivedArticles and reports: 82-003-X19970013057Geography: CanadaDescription: This article updates recently published information on Canadian breast cancer mortality, highlighting a lower rate in 1995, a marked decline in the rate since 1990, and possible factors contributing to this trend.Release date: 1997-07-28
- Articles and reports: 11F0019M1997099Geography: CanadaDescription:
Context : Lung cancer has been the leading cause of cancer deaths in Canadian males for many years, and since 1994, this has been the case for Canadian femalesas well. It is therefore important to evaluate the resources required for its diagnosis and treatment. This article presents an estimate of the direct medical costsassociated with the diagnosis and treatment of lung cancer calculated through the use of a micro-simulation model. For disease incidence, 1992 was chosen as thereference year, whereas costs are evaluated according to the rates that prevailed in 1993.Methods : A model for lung cancer has been incorporated into the Population Health Model (POHEM). The parameters of the model were drawn in part fromStatistics Canada's Canadian Cancer Registry (CCR), which provides information on the incidence and histological classification of lung cancer cases in Canada.The distribution of cancer stage at diagnosis was estimated by using information from two provincial cancer registries. A team of oncologists derived "typical" treatment approaches reflective of current practice, and the associated direct costs were calculated for these approaches. Once this information and the appropriatesurvival curves were incorporated into the POHEM model, overall costs of treatment were estimated by means of a Monte Carlo simulation.Results: It is estimated that overall, the direct medical costs of lung cancer diagnosis and treatment were just over $528 million. The cost per year of life gained as aresult of treatment of the disease was approximately $19,450. For the first time in Canada, it was possible to estimate the five year costs following diagnosis, bystage of the disease at the time of diagnosis. It was possible to estimate the cost per year of additional life gained for three alternative treatments of non small-cell lungcancer (NSCLC). Sensitivity analyses showed that these costs varied between $1,870 and $6,860 per year of additional life gained, which compares favourablywith the costs that the treatment of other diseases may involve.Conclusions: Contrary to widespread perceptions, it appears that the treatment of lung cancer is effective from an economic standpoint. In addition, the use of amicro-simulation model such as POHEM not only makes it possible to incorporate information from various sources in a coherent manner but also offers thepossibility of estimating the effect of alternative medical procedures from the standpoint of financial pressures on the health care system.
Release date: 1997-04-22 - 4. Cancer incidence and mortality, 1997 ArchivedArticles and reports: 82-003-X19960043024Geography: CanadaDescription:
In 1997, there will be an estimated 130,800 new cases of cancer and 60,700 deaths from the disease, an increase of one third and one quarter, respectively, over 1987. These increases are due mainly to the growth and aging of the population. (All figures exclude non-melanoma skin cancer.) In 1997, three types of cancer will account for at least half of all new cases in men and women: prostate, lung and colorectal cancer for men; breast, lung and colorectal cancer for women. Lung cancer will be the leading cause of cancer death in 1997, resulting in one-third of cancer deaths for men and almost one-quarter of cancer deaths for women. Among women, overall trends in age-standardized rates of cancer incidence and mortality have remained relatively stable since 1985, as large increases in the rate of lung cancer have been offset by declining or stable rates for most other forms. Among men, the overall incidence rate is rising slightly as a result of the sharp increase in the incidence of prostate cancer. The mortality rate for men peaked in 1988 and has since declined, because of decreases in the rates for lung, colorectal and some other cancers. This article presents information on trends since the mid-1980s in cancer incidence and mortality, adapted from Canadian Cancer Statistics 1987.
Release date: 1997-04-21
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: